332 related articles for article (PubMed ID: 31387632)
21. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT.
Zhang Y; Li JH; Yuan QG; Cao G; Yang WB
J Cell Biochem; 2019 Aug; 120(8):13651-13657. PubMed ID: 30945341
[TBL] [Abstract][Full Text] [Related]
22. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
23. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
24. Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes.
Meyer C; Godoy P; Bachmann A; Liu Y; Barzan D; Ilkavets I; Maier P; Herskind C; Hengstler JG; Dooley S
J Hepatol; 2011 Aug; 55(2):369-78. PubMed ID: 21184784
[TBL] [Abstract][Full Text] [Related]
25. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.
Wang H; Wang R; Carrera I; Xu S; Lakshmana MK
eNeuro; 2016; 3(2):. PubMed ID: 27257626
[TBL] [Abstract][Full Text] [Related]
26. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
27. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
28. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
29. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway.
Jung DE; Kim JM; Kim C; Song SY
Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908
[TBL] [Abstract][Full Text] [Related]
30. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
31. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
32. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
33. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer.
Zhou C; Qian W; Li J; Ma J; Chen X; Jiang Z; Cheng L; Duan W; Wang Z; Wu Z; Ma Q; Li X
J Exp Clin Cancer Res; 2019 Jul; 38(1):302. PubMed ID: 31296258
[TBL] [Abstract][Full Text] [Related]
34. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
35. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
36. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
[TBL] [Abstract][Full Text] [Related]
38. Effects of RXRα on proliferation and apoptosis of pancreatic cancer cells through TGF-β/Smad signaling pathway.
Chen G; Hu M; Wang XC; Du SH; Cheng ZX; Xu J; Qu YK
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4723-4729. PubMed ID: 31210298
[TBL] [Abstract][Full Text] [Related]
39. YY1 cooperates with TFEB to regulate autophagy and lysosomal biogenesis in melanoma.
Du J; Ren W; Yao F; Wang H; Zhang K; Luo M; Shang Y; O'Connell D; Bei Z; Wang H; Xiong R; Yang Y
Mol Carcinog; 2019 Nov; 58(11):2149-2160. PubMed ID: 31448838
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
